575 related articles for article (PubMed ID: 31185183)
21. Phage therapy for severe bacterial infections: a narrative review.
Petrovic Fabijan A; Khalid A; Maddocks S; Ho J; Gilbey T; Sandaradura I; Lin RC; Ben Zakour N; Venturini C; Bowring B; Iredell JR
Med J Aust; 2020 Apr; 212(6):279-285. PubMed ID: 31587298
[TBL] [Abstract][Full Text] [Related]
22. European regulatory aspects of phage therapy: magistral phage preparations.
Verbeken G; Pirnay JP
Curr Opin Virol; 2022 Feb; 52():24-29. PubMed ID: 34801778
[TBL] [Abstract][Full Text] [Related]
23. Bacteriophages: A Therapy Concept against Multi-Drug-Resistant Bacteria.
Rohde C; Wittmann J; Kutter E
Surg Infect (Larchmt); 2018; 19(8):737-744. PubMed ID: 30256176
[TBL] [Abstract][Full Text] [Related]
24. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
Royer S; Morais AP; da Fonseca Batistão DW
Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
[TBL] [Abstract][Full Text] [Related]
25. Phage Therapy: Going Temperate?
Monteiro R; Pires DP; Costa AR; Azeredo J
Trends Microbiol; 2019 Apr; 27(4):368-378. PubMed ID: 30466900
[TBL] [Abstract][Full Text] [Related]
26. Fitness Trade-Offs between Phage and Antibiotic Sensitivity in Phage-Resistant Variants: Molecular Action and Insights into Clinical Applications for Phage Therapy.
Fujiki J; Nakamura K; Nakamura T; Iwano H
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958612
[TBL] [Abstract][Full Text] [Related]
27. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope.
Kulshrestha M; Tiwari M; Tiwari V
Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110
[TBL] [Abstract][Full Text] [Related]
28. Bacteriophage as an antibacterial agent: a patent perspective.
Pathak-Vaidya P; Sharma S; Telang M
Future Microbiol; 2021 Nov; 16():1327-1339. PubMed ID: 34755539
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.
Dąbrowska K; Abedon ST
Microbiol Mol Biol Rev; 2019 Nov; 83(4):. PubMed ID: 31666296
[TBL] [Abstract][Full Text] [Related]
30. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review.
Kakasis A; Panitsa G
Int J Antimicrob Agents; 2019 Jan; 53(1):16-21. PubMed ID: 30236954
[TBL] [Abstract][Full Text] [Related]
31. Framing the Future with Bacteriophages in Agriculture.
Svircev A; Roach D; Castle A
Viruses; 2018 Apr; 10(5):. PubMed ID: 29693561
[TBL] [Abstract][Full Text] [Related]
32. Reapproaching Old Treatments: Considerations for PK/PD Studies on Phage Therapy for Bacterial Respiratory Infections.
Schmalstig AA; Freidy S; Hanafin PO; Braunstein M; Rao GG
Clin Pharmacol Ther; 2021 Jun; 109(6):1443-1456. PubMed ID: 33615463
[TBL] [Abstract][Full Text] [Related]
33. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields.
Jamal M; Bukhari SMAUS; Andleeb S; Ali M; Raza S; Nawaz MA; Hussain T; Rahman SU; Shah SSA
J Basic Microbiol; 2019 Feb; 59(2):123-133. PubMed ID: 30485461
[TBL] [Abstract][Full Text] [Related]
34. Molecular Machinery of the Triad Holin, Endolysin, and Spanin: Key Players Orchestrating Bacteriophage-Induced Cell Lysis and their Therapeutic Applications.
Samir S
Protein Pept Lett; 2024; 31(2):85-96. PubMed ID: 38258777
[TBL] [Abstract][Full Text] [Related]
35. Phages and their potential to modulate the microbiome and immunity.
Federici S; Nobs SP; Elinav E
Cell Mol Immunol; 2021 Apr; 18(4):889-904. PubMed ID: 32901128
[TBL] [Abstract][Full Text] [Related]
36. A commentary on the development of engineered phage as therapeutics.
Barnard AML; Fairhead HIM
Drug Discov Today; 2021 Sep; 26(9):2095-2098. PubMed ID: 34237459
[TBL] [Abstract][Full Text] [Related]
37. Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections.
Bodier-Montagutelli E; Morello E; L'Hostis G; Guillon A; Dalloneau E; Respaud R; Pallaoro N; Blois H; Vecellio L; Gabard J; Heuzé-Vourc'h N
Expert Opin Drug Deliv; 2017 Aug; 14(8):959-972. PubMed ID: 27776446
[TBL] [Abstract][Full Text] [Related]
38. Advances in the field of phage-based therapy with special emphasis on computational resources.
Bajiya N; Dhall A; Aggarwal S; Raghava GPS
Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36575815
[TBL] [Abstract][Full Text] [Related]
39. Phage Therapy for Antibiotic-Resistant Bacterial Infections.
Hatfull GF; Dedrick RM; Schooley RT
Annu Rev Med; 2022 Jan; 73():197-211. PubMed ID: 34428079
[TBL] [Abstract][Full Text] [Related]
40. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
